Michael W. Dunne made two open market purchases of Iterum Therapeutics plc ($ITRM) shares in the last year, totaling $13,045, with the most recent on November 18, 2025. His activity ranks 4,117th among nearly 5,000 insiders, below the average purchase of $1.46 million across 3.3 transactions. No open market sales reported.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2025 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Not found | P | Ordinary Shares | 6000 | $0.37 | 241,001.0000 | 45,801,927 | 2.55% | 0.01% |
| Aug. 8, 2025 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Not found | P | Ordinary Shares | 15000 | $0.72 | 235,001.0000 | 19,699,260 | 6.82% | 0.08% |
| Aug. 6, 2024 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Not found | M | Warrants (right to buy) | 106247 | $0.00 | 106,247.0000 | 12,962,362 | 9999.99% | 0.82% |
| Aug. 6, 2024 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Not found | M | Warrants (right to buy) | 106247 | $0.00 | 106,247.0000 | 12,962,362 | 9999.99% | 0.82% |
| Aug. 6, 2024 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Not found | M | Ordinary Shares | 106247 | $0.00 | 220,001.0000 | 12,962,362 | 93.40% | 0.82% |
| Aug. 6, 2024 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Not found | M | Subscription Rights (right to buy) | 212494 | $0.00 | 0.0000 | 12,962,362 | 100.00% | 1.64% |
| Dec. 22, 2023 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Director | P | Ordinary Shares | 25000 | $1.40 | 113,754.0000 | 12,236,607 | 28.17% | 0.20% |
| Dec. 18, 2023 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Director | P | Ordinary Shares | 10000 | $1.84 | 88,754.0000 | 12,236,607 | 12.70% | 0.08% |
| Nov. 22, 2023 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Director | P | Ordinary Shares | 20000 | $2.03 | 78,754.0000 | 12,236,607 | 34.04% | 0.16% |
| Oct. 1, 2023 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Director | M | Restricted Share Units | 3487 | $0.00 | 0.0000 | 12,236,607 | 100.00% | 0.03% |
| Oct. 1, 2023 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Director | M | Ordinary Shares | 3487 | $0.00 | 58,754.0000 | 12,236,607 | 6.31% | 0.03% |
| July 1, 2023 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Director | M | Restricted Share Units | 1779 | $0.00 | 0.0000 | 12,236,607 | 100.00% | 0.01% |
| July 1, 2023 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Director | M | Ordinary Shares | 1779 | $0.00 | 55,267.0000 | 12,236,607 | 3.33% | 0.01% |
| June 15, 2023 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Director | M | Ordinary Shares | 15853 | $0.00 | 53,488.0000 | 12,236,607 | 42.12% | 0.13% |
| June 15, 2023 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Director | M | Restricted Share Units | 15853 | $0.00 | 0.0000 | 12,236,607 | 100.00% | 0.13% |
| April 1, 2023 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Director | M | Ordinary Shares | 1299 | $0.00 | 37,635.0000 | 12,236,607 | 3.57% | 0.01% |
| April 1, 2023 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Director | M | Restricted Share Units | 1299 | $0.00 | 0.0000 | 12,236,607 | 100.00% | 0.01% |
| April 1, 2023 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Director | M | Ordinary Shares | 1299 | $0.00 | 37,636.0000 | 12,236,607 | 3.57% | 0.01% |
| Jan. 1, 2023 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Director | M | Ordinary Shares | 761 | $0.00 | 36,337.0000 | 12,236,607 | 2.14% | 0.01% |
| Jan. 1, 2023 | Iterum Therapeutics plc | $ITRM | Dunne Michael W. | Director | M | Restricted Share Units | 761 | $0.00 | 0.0000 | 12,236,607 | 100.00% | 0.01% |